Official websites use. Share sensitive information only on official, secure websites. Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor s. The publisher and the editor s disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. The updated evidence-based treatment recommendation for early breast cancer EBC and metastatic breast cancer of the AGO Task Force has been released.
A multidisciplinary team is a prerequisite for optimal management of breast cancer. The full version of the updated slide set including annotated speeches of each chapter is available online www.
In addition, there is a version for patients from this live event available. This update has been performed according to a documented algorithm, by thoroughly reviewing and scoring chapter by chapter the most recent and relevant publications for their scientific validity Oxford level of evidence LoE [ 2 ] and clinical relevance AGO grades of recommendation; Table 1 , 2 , 3.
